Corbion, a global leader in sustainable ingredients, and Brain Biotech AG, a pioneer in specialty enzyme and microbial technology, have announced a strategic collaboration to develop innovative biobased antimicrobial compounds and derivatives. This partnership aims to accelerate the creation of natural preservation solutions for food manufacturers while meeting growing consumer demand for clean-label, nature-based products.

“At Corbion, advancing nature-based ingredient technologies and demonstrating their efficacy is central to our mission of preserving what matters,” said Domenico Vulcano, Vice President of Global Innovation at Corbion. “Collaborating with Brain Biotech allows us to combine our expertise in food systems with their pioneering microbial and enzyme technologies, bringing the next generation of sustainable food preservation solutions to market faster.”

Brain Biotech contributes its strengths in specialty enzyme technology, microbial strain development, and bioprocess innovation, along with experience as a technology licensing partner. Corbion complements this with deep insights into food systems, biobased preservation, and large-scale piloting and commercialization capabilities.

“We are thrilled to collaborate with Corbion to unlock new possibilities in sustainable, bio-based solutions,” said Dr. Martin Langer, Managing Director & Executive Vice President at BRAIN Biotech AG. “Our shared vision, complementary expertise, and strong partnership will deliver meaningful innovation that benefits food manufacturers and consumers worldwide.”